Verenium, Tate & Lyle partner for new enzyme

February 1, 2012 |

In California, Verenium and Tate & Lyle have signed an agreement for the use of one of Verenium’s proprietary enzyme products in the development of novel food ingredients.  Under the terms of the agreement, Tate & Lyle receives a technology license with exclusivity assurances in the field of development. Verenium receives $1.5 million in near term milestone payments, revenues from enzyme product sales, and a royalty on Tate & Lyle’s future sales.

Print Friendly, PDF & Email

Tags: ,

Category: Dashboard

Thank you for visting the Digest.